Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma

Cancer

Volumn 112, Issue 2, 2008, Pages 345-351

  Rusthoven, Kyle ^a   Ballonoff, Ari ^a   Raben, David ^a   Chen, Changhu ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Head and neck cancer; Oral cavity cancer; Oral tongue cancer; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

ADULT; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; SEER PROGRAM; SURVIVAL RATE; TONGUE NEOPLASMS;

EID: 38049010355     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23183     Document Type: Article

References (30)

1. American Cancer Society Web site. Key statistics for oral cavity and oropharyngeal cancer. Available from URL: http://www.cancer.org/docroot/CRI/ content/ CRI_2_4_1X_What_are_the_key_statistics_for_oral_cavity_and_oropharyngeal_ cancer_60.asp Accessed May 23, 2007.
2. Prince S, Bailey BMW. Squamous carcinoma of the tongue: review. Br J Oral Maxillofac Surg. 1999;37:164-174.
3. Shemen LJ, Klotz J, Schottenfeld D, Strong EW. Increase in tongue cancer in young men [letter]. JAMA. 1984;252:1857.
4. Depue P. Rising mortality from cancer of the tongue in young adults [letter]. N Engl J Med. 1986;315:647.
5. Davis S, Severson R. Increasing incidence of cancer of the tongue in young adults. Lancet. 1987;2:910-911.
6. Yao M, Chang K, Funk GF, et al. The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy - the University of Iowa experience. Int J Radiat Oncol Biol Phys. 2007;67:1332-1341.
7. Bell RB, Kademani D, Homer L, Dierks EJ, Potter BE. Tongue cancer: is there a difference in survival compared with other subsites in the oral cavity? J Oral Maxillofac Surg. 2007;65:229-236.
8. Hankey BF, Ries LA, Edwards BK. The Surveillance, Epidemiology and End-Results Program: a national resource. Cancer Epidemiol Biomarkers Prev. 1999;8:1117-1121.
9. Harlan LC, Hankey BF. The Surveillance, Epidemiology and End-Results Program database as a resource for conducting descriptive epidemiologic and clinical studies. J Clin Oncol. 2003;21:2232-2233.
10. Surveillance, Epidemiology, and End-Results Program Web site. Available at URL: http://seer.cancer.gov/about/Accessed May 4, 2007.
11. Surveillance, Epidemiology, and End-Results Program Web site. Available at URL: http://seer.cancer.gov/data/access.html Accessed May 4, 2007.
12. Greene FL, Page DL, Fleming ID, et al. eds. AJCC Cancer Staging Manual 6th ed. New York, NY: Springer-Verlag; 2002.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
14. Mantel N. Evaluation of survival data and 2 new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.
15. Cox DR. Regression models and life-tables. J. R Stat Soc B. 1972;34:187-202.
16. SEER*Stat Version 6.3.5. Bethesda, Md: National Cancer Institute; 2007. Available at URL: http://seer.cancer.gov/seerstat Accessed May 4, 2007.
17. Sathyan KM, Sailasree R, Jayasurya R, et al. Carcinoma of the tongue and buccal mucosa represent different biological subentities of the oral carcinoma. J Cancer Res Clin Oncol. 2006;132:601-609.
18. Schwartz JL, Gu X, Kittles RA, Baptiste A, Shklar G. Experimental oral carcinoma of the tongue and buccal mucosa: possible biological markers linker to cancer at 2 anatomic sites. Oral Oncol. 2000;36:225-235.
19. Lingen MW, Chang KW, McMurray SJ, et al. Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9. Head Neck. 2000;22:328-335.
20. Overgaard J, Sand Hansen H, Specht L, et al. Five compared with 6 fractions per week of conventional radiotherapy of squamous-cell carcinoma of the head and neck: DAHANCA 6&7 randomised controlled trial. Lancet. 2003;362:933-940.
21. Adelstein DJ, Saxton JP, Rybicki LA, et al. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution. J Clin Oncol. 2006;24:1064-1071.
22. Peters LJ, Goepfert H, Ang KK, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys. 1993;26:3-11.
23. Lehman RH, Cox JD, Belson TP, et al. Recurrence patterns by treatment modality of carcinoma of the floor of the mouth and oral tongue. Am J Otolaryngol. 1982;3:174-181.
24. Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51:571-578.
25. Cooper JS, Pajak TF, Forasteirre AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937-1944.
26. Hicks WL Jr, North JH Jr, Loree TR, et al. Surgery as a single modality therapy for squamous cell carcinoma of the oral tongue. Am J Otolaryngol. 1998;19:24-28.
27. Sessions DG, Spector GJ, Lenox J, Haughey B, Chao C, Marks J. Analysis of treatment results for oral tongue cancer. Laryngoscope. 2002;112:616-625.
28. Garavello W, Spreaflco R, Gaini RM. Oral tongue cancer in young patients: a matched analysis. Oral Oncol. 2007;43:894-897.
29. Pittman KT, Johnson JT, Wagner RL, Myers EN. Cancer of the tongue in patients less than forty. Head Neck. 2000;22:297-302.
30. Manuel S, Raghavan SK, Pandey M, Sebastian P. Survival in patients under 45 with squamous cell carcinoma of the oral tongue. J Oral Maxillofac Surg. 2003;32:167-173.